Skip to content

ABN AMRO INVESTMENT SOLUTIONS: CLX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ABN AMRO INVESTMENT SOLUTIONS on CLX, newest first. How the timeline and the estimate are built.

ABN AMRO INVESTMENT SOLUTIONS held 9,225 CLX shares at 2026-06-30 per its 13F-HR filed 2026-07-23.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 9,225 shares
    Change vs previous 13F +4,243 shares

    0.01% of the 13F portfolio, value $880,434.

    13F-HR 0002080520-26-000003 filed by ABN AMRO INVESTMENT SOLUTIONS
    Filed (acceptance time not in the bulk data set), ingested

    • ABN AMRO Bank N.V.: 2,250 shares (included in another member's report, not added)
    • ABN AMRO INVESTMENT SOLUTIONS: 9,225 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,982 shares
    Change vs previous 13F -1,056 shares

    0.01% of the 13F portfolio, value $516,285.

    13F-HR 0002080520-26-000002 filed by ABN AMRO INVESTMENT SOLUTIONS
    Filed (acceptance time not in the bulk data set), ingested

    • ABN AMRO Bank N.V.: 2,250 shares (included in another member's report, not added)
    • ABN AMRO INVESTMENT SOLUTIONS: 4,982 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,038 shares
    Change vs previous 13F +3,788 shares

    0.01% of the 13F portfolio, value $608,812.

    13F-HR 0002080520-26-000001 filed by ABN AMRO INVESTMENT SOLUTIONS
    Filed (acceptance time not in the bulk data set), ingested

    • ABN AMRO Bank N.V.: 2,250 shares (included in another member's report, not added)
    • ABN AMRO INVESTMENT SOLUTIONS: 6,038 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,250 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $275,761.

    13F-HR 0001561082-25-000019 filed by ABN AMRO Bank N.V.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).